This post was originally published on this site
The company has also finalized an initial order from the government for 50 million needles and syringes to be delivered by the end of December 2020.
The investment is under a public-private partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Health and Human Services Office, Becton Dickinson said.
BARDA has invested more than $3 billion in vaccines and funded more than 30 projects as part of “Operation Warp Speed,” the White House program aimed at accelerating access to vaccines and treatments for the new coronavirus.
BARDA will get priority access to the injection devices from the new manufacturing lines, the company said.
